Home › Focal Segmental Glomerulosclerosis › Florida › Miami
Focal Segmental Glomerulosclerosis clinical trials in Miami, FL
6 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- Total Research Group, LLC, Miami
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
- Investigator Site #7, Miami
Nephrotic Syndrome Study Network
RecruitingObservational study
- University of Miami Miller School of Medicine, Miami
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- University of Miami, Leonard M. Miller School of Medicine, Miami
- Nicklaus Children's Hospital, Miami
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- Nicklaus Children's Hospital, Miami
Proteinuria in Pre and Post Transplant
RecruitingObservational study
- University of Miami Miller School of Medicine Transplant Clinic, Miami
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Queens, NY6 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
- Cleveland, OH4 studies
- Dallas, TX4 studies
- Kansas City, MO4 studies
- Chicago, IL4 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.